Related Experiment Videos
Resource costing for multinational neurologic clinical trials: methods and results
K Schulman1, J Burke, M Drummond
1Clinical Economics Research Unit, Georgetown University Medical Center, Washington, DC 20007, USA.
Health Economics
|December 9, 1998
Summary
This study developed a framework for multinational resource costing to accurately estimate healthcare costs for new medical technologies. The findings provide crucial unit costs for patient and hospital services across seven countries.
Area of Science:
- Health Economics
- Medical Technology Assessment
- Clinical Trial Costing
Background:
- Economic evaluations of new medical technologies require accurate international cost data.
- Subarachnoid hemorrhage treatment presents unique costing challenges in multinational clinical trials.
Purpose of the Study:
- To present a framework for collecting and analyzing international resource cost data.
- To establish consistent and accurate intercountry cost estimations for a new medical technology.
- To develop study unit costs for patient and hospital services.
Main Methods:
- Collected cost data from seven participating countries (Australia, France, Germany, UK, Italy, Spain, Sweden).
- Utilized structured worksheets for efficient and accurate cost reporting.
- Employed market-basket approach and resource-based relative value units for cost estimation when direct data was unavailable.
- Converted costs to a common currency using purchasing power parity measures.
Main Results:
- Developed a set of unit costs for patient services and per diem hospital services.
- Successfully implemented a framework for multinational resource costing.
- Provided a basis for prospective economic evaluation of a new medical technology.
Conclusions:
- The developed framework facilitates consistent and accurate intercountry cost estimation.
- Guidelines are suggested for more effective multinational costing exercises.
- The study provides valuable unit costs for economic evaluations in healthcare.